PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
30-Jan-2024 OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry OPEN X Health
30-Jan-2024 HUTCHMED Receives ELUNATE® (fruquintinib) Marketing Approval in Hong Kong for Treatment of Metastatic Colorectal Cancer HUTCHMED
30-Jan-2024 Cresset Aims to Optimise Drug Discovery with Latest Drug Design Platform Release Cresset
30-Jan-2024 RECOMMENDED ALL-SHARE ACQUISITION OF THE ASSETS OF ARIX BIOSCIENCE PLC ("Arix") RTW BIOTECH OPPORTUNITIES LTD ("RTW Bio")
30-Jan-2024 Data on over 2,300 Lung Cancer Biomarkers Mapped in New Global Database Beacon Intelligence
30-Jan-2024 Board appointments Cambridge Cognition
30-Jan-2024 Trading Update Cambridge Cognition
29-Jan-2024 Aripiprazole once-every-two-months long-acting injectable recommended for approval in the EU by the CHMP for the maintenance treatment of schizophrenia in adult patients stabilised with aripiprazole Otsuka Pharmaceutical
29-Jan-2024 Update on Regulatory Review of leriglitazone in the EU Minoryx Therapeutics
29-Jan-2024 LILLY RECEIVES MHRA MARKETING AUTHORISATION IN GREAT BRITAIN FOR TIRZEPATIDE (MOUNJARO ®▼) IN ALTERNATIVE KWIKPEN® PRESENTATION FOR TWO INDICATIONS Lilly
29-Jan-2024 Cherwell launches Redipor® Beta Bags to support continuous manufacturing of sterile medicinal products Cherwell
26-Jan-2024 Cognizant Helping to Modernise Infrastructure and Application Management as Part of Takeda’s Digital Transformation Cognizant 
26-Jan-2024 Biomunex Pharmaceuticals announces the start of a Phase 1 clinical trial for its first-in-class bispecific antibody for the treatment of cancer Biomunex Pharmaceuticals (Biomunex)
26-Jan-2024 Eliminating cervical cancer across the UK could save the economy £2.6 billion, new research finds OHE
26-Jan-2024 Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases Kyowa Kirin
24-Jan-2024 Otsuka announces topline results from Ionis’ Phase 3 OASIS-HAE study of investigational donidalorsen in patients with hereditary angioedema Otsuka Pharmaceutical Europe Ltd
23-Jan-2024 Leading biometrics CRO Phastar to share vast statistical expertise with biotechs working to build the drugs of the future Phastar
23-Jan-2024 YPrime Unveils a Transformative Brand Focused on Solving for Certainty in Clinical Trials YPrime
22-Jan-2024 Bayer receives MHRA authorisation for EYLEA® 8mg (aflibercept) for two sight-threatening macular conditions Bayer
22-Jan-2024 Calibre Scientific Acquires RUWAG, a Swiss Provider of Diagnostics and Life Sciences Products and Services Calibre Scientific